Successful Transition from Pediatric to Adult Care in Inflammatory Bowel Disease: What is the Key?

Overview

Journal Pediatr Gastroenterol Hepatol Nutr

Date 2019 Jan 24

PMID 30671371

Citations 8

Authors

Jeongseok Kim

Byong Duk Ye

Affiliations

Soon will be listed here.

Abstract

The incidence of pediatric-onset inflammatory bowel disease (IBD) is on the rise, accounting for up to 25% of IBD cases. Pediatric IBD often has extensive bowel involvement with aggressive and rapidly progressing behavior compared to adult IBD. Because IBD has a high morbidity rate and can have a lifelong impact, successful transition from pediatric to adult care is important to maintain the continuity of care. Furthermore, successful transition facilitates appropriate development and psychosocial well-being among patients, as well as comprehensive and harmonious healthcare delivery amongst stakeholders. However, there are various obstacles related to patients, family, providers, and organizations that interfere with successful transition. Successful transition requires a flexible and tailored plan that is made according to the patient's developmental abilities and situation. This plan should be established through periodic interviews with the patient and family and through close collaboration with other care providers. Through a stepwise approach to the transition process, patients' knowledge and self-management skills can be improved. After preparation for the transition is completed and the obstacles are overcome, patients can be gradually moved to adult care. Finally, successful transition can increase patients' adherence to therapy, maintain the appropriate health status, improve patients' self-management, and promote self-reliance among patients.

Citing Articles

Detailed immune profiling in pediatric Crohn's disease using methylation cytometry.

Reynolds S, Salas L, Chen J, Christensen B Epigenetics. 2023; 19(1):2289786.

PMID: 38090774 PMC: 10761011. DOI: 10.1080/15592294.2023.2289786.

Transition Readiness Into Adult Health Care in Children With Inflammatory Bowel Disease.

Alsufyani H, Jar S, Jambi W, Meer N, Bajunaid W, Albaradei H Cureus. 2023; 15(10):e46825.

PMID: 37954806 PMC: 10636568. DOI: 10.7759/cureus.46825.

Barriers to and requirements for a successful transition in inflammatory bowel disease from pediatric to adult care in Greece.

Giouleme O, Koutsoumourakis A, Katsoula A, Katsaros M, Soufleris K, Vasilaki K Ann Gastroenterol. 2023; 36(5):541-548.

PMID: 37664230 PMC: 10433259. DOI: 10.20524/aog.2023.0817.

Characteristics and Treatment Outcomes of Transition among Patients with Inflammatory Bowel Disease.

Yoo E, Cho S, Park S, Kim T, Kim W, Cheon J Yonsei Med J. 2023; 64(9):541-548.

PMID: 37634630 PMC: 10462809. DOI: 10.3349/ymj.2022.0588.

Transition from pediatric to adult care among patients with epilepsy: Cross-sectional surveys of experts and patients in Korea.

Jung S, Yu S, Lee K, Yi Y, Kang J Epilepsia Open. 2022; 7(3):452-461.

PMID: 35766448 PMC: 9436304. DOI: 10.1002/epi4.12621.

References

Baldassano R, Ferry G, Griffiths A, Mack D, Markowitz J, Winter H . Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2002; 34(3):245-8. DOI: 10.1097/00005176-200203000-00001. View

. A consensus statement on health care transitions for young adults with special health care needs. Pediatrics. 2002; 110(6 Pt 2):1304-6. View

Ballinger A, Savage M, Sanderson I . Delayed puberty associated with inflammatory bowel disease. Pediatr Res. 2003; 53(2):205-10. DOI: 10.1203/01.PDR.0000047510.65483.C9. View

Griffiths A . Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol. 2004; 18(3):509-23. DOI: 10.1016/j.bpg.2004.01.002. View

Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V . Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Dig Liver Dis. 2004; 36(5):342-7. DOI: 10.1016/j.dld.2003.12.014. View

Heyman M, Kirschner B, Gold B, Ferry G, Baldassano R, Cohen S . Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005; 146(1):35-40. DOI: 10.1016/j.jpeds.2004.08.043. View

Davies J, Evans B, Gregory J . Bone mass acquisition in healthy children. Arch Dis Child. 2005; 90(4):373-8. PMC: 1720329. DOI: 10.1136/adc.2004.053553. View

Mackner L, Crandall W . Oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005; 11(11):1006-12. DOI: 10.1097/01.mib.0000186409.15392.54. View

Hait E, Arnold J, Fishman L . Educate, communicate, anticipate-practical recommendations for transitioning adolescents with IBD to adult health care. Inflamm Bowel Dis. 2005; 12(1):70-3. DOI: 10.1097/01.mib.0000194182.85047.6a. View

10.

Bernstein C, Wajda A, Svenson L, MacKenzie A, Koehoorn M, Jackson M . The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006; 101(7):1559-68. DOI: 10.1111/j.1572-0241.2006.00603.x. View

11.

Paul T, Birnbaum A, Pal D, Pittman N, Ceballos C, LeLeiko N . Distinct phenotype of early childhood inflammatory bowel disease. J Clin Gastroenterol. 2006; 40(7):583-6. DOI: 10.1097/00004836-200608000-00004. View

12.

Vaisman N, Dotan I, Halack A, Niv E . Malabsorption is a major contributor to underweight in Crohn's disease patients in remission. Nutrition. 2006; 22(9):855-9. DOI: 10.1016/j.nut.2006.05.013. View

13.

Walters T, Gilman A, Griffiths A . Linear growth improves during infliximab therapy in children with chronically active severe Crohn's disease. Inflamm Bowel Dis. 2007; 13(4):424-30. DOI: 10.1002/ibd.20069. View

14.

Oliva-Hemker M, Abadom V, Cuffari C, Thompson R . Nonadherence with thiopurine immunomodulator and mesalamine medications in children with Crohn disease. J Pediatr Gastroenterol Nutr. 2007; 44(2):180-4. DOI: 10.1097/MPG.0b013e31802b320e. View

15.

Kappelman M, Rifas-Shiman S, Kleinman K, Ollendorf D, Bousvaros A, Grand R . The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007; 5(12):1424-9. DOI: 10.1016/j.cgh.2007.07.012. View

16.

Heuschkel R, Salvestrini C, Beattie R, Hildebrand H, Walters T, Griffiths A . Guidelines for the management of growth failure in childhood inflammatory bowel disease. Inflamm Bowel Dis. 2008; 14(6):839-49. DOI: 10.1002/ibd.20378. View

17.

Hommel K, Davis C, Baldassano R . Medication adherence and quality of life in pediatric inflammatory bowel disease. J Pediatr Psychol. 2008; 33(8):867-74. PMC: 2493513. DOI: 10.1093/jpepsy/jsn022. View

18.

Dabadie A, Troadec F, Heresbach D, Siproudhis L, Pagenault M, Bretagne J . Transition of patients with inflammatory bowel disease from pediatric to adult care. Gastroenterol Clin Biol. 2008; 32(5 Pt 1):451-9. DOI: 10.1016/j.gcb.2008.01.044. View

19.

Vernier-Massouille G, Balde M, Salleron J, Turck D, Dupas J, Mouterde O . Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology. 2008; 135(4):1106-13. DOI: 10.1053/j.gastro.2008.06.079. View

20.

Van Limbergen J, Russell R, Drummond H, Aldhous M, Round N, Nimmo E . Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008; 135(4):1114-22. DOI: 10.1053/j.gastro.2008.06.081. View